Enhanced Liver Fibrosis (ELF™)  Virtual Webinar

Register for a Virtual Webinar to learn about hoe the ELF™ Test helps improve the assessment of NAFLD/NASH and chronic liver disease patients at risk of disease progression.

DATE: TBD
Mid-June 2022

Please pre-register below for the Enhanced Liver Fibrosis (ELF™) Virtual Webinar taking place mid-June 2022.

In this Virtual Webinar, we'll explore:

• Different diagnostic and care pathways from other parts of the world in order to increase awareness on Non-Invasive serum markers and how they can be used to refine NAFLD/NASH patient referrals to liver specialists.
• How blood-based tests can readily support high-volume testing, do not require patient access to specialized imaging equipment or highly trained operators, and generally have lower incidence rates of failure and unreliable results reported for imaging modalities.
• How incorporating a fast and simple blood test can help enhance patient management with a test that has been shown to outperform biopsy for the risk assessment of progression to cirrhosis and liver-related clinical events (LREs).

If you have any questions, please reach out to our ELF Business Manager, Martin Gendron at:
martin.gendron@siemens-healthineers.com.